Filtros : "Financiamento Guangdong Basic and Applied Basic Research Foundation" "Reino Unido" Limpar

Filtros



Refine with date range


  • Source: Acta Materialia. Unidade: EESC

    Subjects: FILMES FINOS, NANOCOMPOSITOS, DESGASTE DOS MATERIAIS

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      QING, Zhou et al. Wear-resistant CrCoNi nanocrystalline film via friction-driven surface segregation. Acta Materialia, v. 279, p. 1-16, 2024Tradução . . Disponível em: http://dx.doi.org/10.1016/j.actamat.2024.120299. Acesso em: 16 nov. 2025.
    • APA

      Qing, Z., Zhichao Jiao,, Yeran, S., Yulong, L., Cunhong, Y., Haifeng, W., et al. (2024). Wear-resistant CrCoNi nanocrystalline film via friction-driven surface segregation. Acta Materialia, 279, 1-16. doi:10.1016/j.actamat.2024.120299
    • NLM

      Qing Z, Zhichao Jiao, Yeran S, Yulong L, Cunhong Y, Haifeng W, Pinto HC, Greiner C, Weimin L. Wear-resistant CrCoNi nanocrystalline film via friction-driven surface segregation [Internet]. Acta Materialia. 2024 ; 279 1-16.[citado 2025 nov. 16 ] Available from: http://dx.doi.org/10.1016/j.actamat.2024.120299
    • Vancouver

      Qing Z, Zhichao Jiao, Yeran S, Yulong L, Cunhong Y, Haifeng W, Pinto HC, Greiner C, Weimin L. Wear-resistant CrCoNi nanocrystalline film via friction-driven surface segregation [Internet]. Acta Materialia. 2024 ; 279 1-16.[citado 2025 nov. 16 ] Available from: http://dx.doi.org/10.1016/j.actamat.2024.120299
  • Source: Drug Resistance Updates. Unidade: IQ

    Subjects: NEOPLASIAS, PURINAS, PROLIFERAÇÃO CELULAR

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      JIA, Wenhui et al. Purinergic signalling in cancer therapeutic resistance: From mechanisms to targeting strategies. Drug Resistance Updates, v. 70, p. 1-13 art. 100988, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.drup.2023.100988. Acesso em: 16 nov. 2025.
    • APA

      Jia, W., Huang, Z., Zhou, L., Liou, Y. -C., Virgilio, F. D., Ulrich, H., et al. (2023). Purinergic signalling in cancer therapeutic resistance: From mechanisms to targeting strategies. Drug Resistance Updates, 70, 1-13 art. 100988. doi:10.1016/j.drup.2023.100988
    • NLM

      Jia W, Huang Z, Zhou L, Liou Y-C, Virgilio FD, Ulrich H, Peter I, Zhang W, Huang C, Tang Y. Purinergic signalling in cancer therapeutic resistance: From mechanisms to targeting strategies [Internet]. Drug Resistance Updates. 2023 ; 70 1-13 art. 100988.[citado 2025 nov. 16 ] Available from: https://doi.org/10.1016/j.drup.2023.100988
    • Vancouver

      Jia W, Huang Z, Zhou L, Liou Y-C, Virgilio FD, Ulrich H, Peter I, Zhang W, Huang C, Tang Y. Purinergic signalling in cancer therapeutic resistance: From mechanisms to targeting strategies [Internet]. Drug Resistance Updates. 2023 ; 70 1-13 art. 100988.[citado 2025 nov. 16 ] Available from: https://doi.org/10.1016/j.drup.2023.100988
  • Source: Signal Transduction and Targeted Therapy. Unidade: IQ

    Subjects: PURINAS, DOENÇAS NEURODEGENERATIVAS

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      HUANG, Zhao et al. From purines to purinergic signalling: molecular functions and human diseases. Signal Transduction and Targeted Therapy, v. 6, p. 1-20 art. 162, 2021Tradução . . Disponível em: https://doi.org/10.1038/s41392-021-00553-z. Acesso em: 16 nov. 2025.
    • APA

      Huang, Z., Xie, N., Illes, P., Virgilio, F. D., Ulrich, H., Semyanov, A., et al. (2021). From purines to purinergic signalling: molecular functions and human diseases. Signal Transduction and Targeted Therapy, 6, 1-20 art. 162. doi:10.1038/s41392-021-00553-z
    • NLM

      Huang Z, Xie N, Illes P, Virgilio FD, Ulrich H, Semyanov A, Verkhratsky A, Sperlagh B, Yu S-G, Huang C, Tang Y. From purines to purinergic signalling: molecular functions and human diseases [Internet]. Signal Transduction and Targeted Therapy. 2021 ; 6 1-20 art. 162.[citado 2025 nov. 16 ] Available from: https://doi.org/10.1038/s41392-021-00553-z
    • Vancouver

      Huang Z, Xie N, Illes P, Virgilio FD, Ulrich H, Semyanov A, Verkhratsky A, Sperlagh B, Yu S-G, Huang C, Tang Y. From purines to purinergic signalling: molecular functions and human diseases [Internet]. Signal Transduction and Targeted Therapy. 2021 ; 6 1-20 art. 162.[citado 2025 nov. 16 ] Available from: https://doi.org/10.1038/s41392-021-00553-z

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2025